Clinical trials
Phase 1/2 Coronavirus Infections trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
47 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 31 |
| 2021 | 9 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 26 |
| Unknown status | 12 |
| Terminated | 6 |
| Not yet recruiting | 1 |
| Recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2 |
| Regeneron Pharmaceuticals | 2 |
| Sohaib Ashraf | 2 |
| University of Oxford | 2 |
| Alkarkh Health Directorate-Baghdad | 1 |
| Apellis Pharmaceuticals, Inc. | 1 |
| Arcturus Therapeutics, Inc. | 1 |
| Artgen Biotech | 1 |
| Aspire Health Science | 1 |
| Beth Israel Deaconess Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Coronavirus Infections | 47 |
| COVID-19 | 37 |
| Pneumonia | 7 |
| Respiratory Distress Syndrome | 7 |
| Virus Diseases | 6 |
| Lung Diseases | 3 |
| Pneumonia, Viral | 3 |
| Respiratory Tract Infections | 3 |
| Severe Acute Respiratory Syndrome | 3 |
| Acute Lung Injury | 2 |
Trials
Showing 76 to 47 of 47. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.